CN110038089A - A kind of Chinese herbal granules and preparation method thereof for treating hypertension - Google Patents

A kind of Chinese herbal granules and preparation method thereof for treating hypertension Download PDF

Info

Publication number
CN110038089A
CN110038089A CN201910231256.6A CN201910231256A CN110038089A CN 110038089 A CN110038089 A CN 110038089A CN 201910231256 A CN201910231256 A CN 201910231256A CN 110038089 A CN110038089 A CN 110038089A
Authority
CN
China
Prior art keywords
parts
rhizoma
chinese herbal
treatment
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910231256.6A
Other languages
Chinese (zh)
Inventor
刘宏智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Chang Eternal Biotechnology Co Ltd
Original Assignee
Hainan Chang Eternal Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Chang Eternal Biotechnology Co Ltd filed Critical Hainan Chang Eternal Biotechnology Co Ltd
Priority to CN201910231256.6A priority Critical patent/CN110038089A/en
Publication of CN110038089A publication Critical patent/CN110038089A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/646Arachnids, e.g. spiders, scorpions, ticks or mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296Epimedium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533Leonurus (motherwort)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536Prunella or Brunella (selfheal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/884Alismataceae (Water-plantain family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964Anemarrhena
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Abstract

The present invention relates to a kind of Chinese herbal granules and preparation method thereof for treating hypertension, the Chinese herbal granules include following ingredient by percentage to the quality: drop smells good 10-20 parts, 2-8 parts of rhizoma cyperi, 5-15 parts of rhizoma anemarrhenae, 5-15 parts of Cortex Phellodendri, 5-15 parts of HERBA EPIMEDII, 20-40 parts of Huai wheat, 20-40 parts of uncaria and 20-40 parts of mother-of-pearl.The Chinese herbal granules and preparation method thereof for the treatment of hypertension provided by the invention, significant in efficacy, Small side effects and treatment cycle is short.

Description

A kind of Chinese herbal granules and preparation method thereof for treating hypertension
Technical field
The present invention relates to the Chinese patent drug technique fields for the treatment of hypertension, and in particular to a kind of Chinese medicinal granule for treating hypertension Agent and preparation method thereof.
Background technique
It with arterial pressure raising is the cardiovascular disease mainly showed that hypertension (Hypertension), which is a kind of, either It is all a kind of common disease in developed country or developing country.The treatment of hypertension at present is high about treatment based on Western medicine The drug report of blood pressure is growing day by day in recent years.
Often mechanism of action is single for previous antihypertensive drugs, like great fish is harnessed the river using the method crammed and cut is buried, although blood pressure Be controlled, but bring many adverse reactions, as angiotensin converting enzyme inhibitor (ACEI) class drug it is significant not Good reaction is cough.And traditional Chinese medicine is more to the treatment method and means of hypertension, like Yu Zhishui takes the side built canals and dredged Formula not only can effectively be depressured and have certain protective effect to each related internal organs.The fact that given counterevidence and participate in blood pressure control Mechanism is various.People gradually recognize this point in recent years, start the medication combined control using different role mechanism Blood pressure.And Chinese medicine action temperature and, meet the principle being steadily depressured, adverse reaction is small, can obviously improve symptom, cheap, Patient acceptability is good.Concern and investment recently as country to tcm field, the antihypertensive research of Chinese medicine and application There is sustainable development.
Oblique leaf yellow wingceltis Dalbergia pinnata (Lour.) Prain is pulse family yellow wingceltis platymiscium, also known as tiltedly leaf wingceltis, main product In the areas such as China Hainan, Guangxi, Yunnan, Tibet and Burma, Indonesia.It is recorded in " Chinese Plants will ", and " complete stool can It is medicinal, control rheumatism, bruise, bruise, there is the benefits of swelling and pain relieving ", because its xylem is rich in anime, ancient times, imperial palace high ranking official was expensive The fragrant material that race once will be enriched in anime is used as stacte raw material, and is referred to as fragrant product drop and smells good, while fragrant material is also used in ancient battlefield Make hemostatic.Recognize that China Hainan, Yunnan etc. are civil by civil visit and investigate oblique leaf yellow wingceltis perfume (or spice) material is considered as treasure, commonly uses In steeping in wine or folk prescription application, adjuvant therapy of cardiovascular disease, diabetes, respiratory disease, rheumatalgia, acute gastroenteritis and bruise Damage, empyrosis, snakeworm such as bite at the wounds, have long Medicinal history.
Drop smell good volatile oil main component be elemicin, methyl eugenol, 4- allyl -2,6- syringol, Whiskey lactone etc..Elemi is known as the effects of stronger hypnosis, mosquito repellent desinsection, antimycotic, anti-pneumonia;Methyl eugenol has drop The effects of pressing, be anti-oxidant, antibacterial;4- allyl -2,6- syringol has anti-lipid peroxidation effect, and has clear Except antioxidations such as free radicals;Whiskey lactone has the effects that stronger antibacterial, anti-inflammatory and anti-oxidant.Due to oblique leaf yellow wingceltis Main component has functional activity in essential oil, thus can be used as it is a kind of calm the nerves, the raw material of the drugs such as anti-oxidant, antibacterial, anti-inflammatory.
Summary of the invention
A kind of mechanism of action is sound and the depressor of Small side effects to provide, and the present invention provides a kind of hypertension for the treatment of Chinese herbal granules, including following ingredient by percentage to the quality: dropping smell good 10-20 parts, 2-8 parts of rhizoma cyperi, 5-15 parts of rhizoma anemarrhenae, Huang 5-15 parts of cypress, 5-15 parts of HERBA EPIMEDII, 20-40 parts of Huai wheat, 20-40 parts of uncaria and 20-40 parts of mother-of-pearl.
Wherein, the content of each ingredient is as follows by percentage to the quality: dropping smell good 15 parts, 5 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, Cortex Phellodendri 10 parts, 10 parts of HERBA EPIMEDII, 30 parts of Huai wheat, 30 parts of uncaria and 30 parts of mother-of-pearl.
Wherein, further include following ingredient by percentage to the quality: 15-25 parts of mulberry fruit, 4-10 parts of Rhizoma Chuanxiong, radix achyranthis bidentatae 6-10 Part, 5-8 parts of motherwort, 8-12 parts of semen ziziphi spinosae, 9-15 parts of fructus gardeniae, 2-6 parts of the shell of seaear, 10-20 parts of pueraria lobata and rhizoma alismatis 10-20 Part.
Wherein, further include following ingredient by percentage to the quality: 20 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 8 parts of radix achyranthis bidentatae, motherwort 7 Part, 10 parts of semen ziziphi spinosae, 12 parts of fructus gardeniae, 4 parts of the shell of seaear, 15 parts of pueraria lobata and 15 parts of rhizoma alismatis.
Wherein, further include following ingredient by percentage to the quality: 2-4 parts of Prunella vulgaris, 2-4 parts of leech, 2-4 parts of scorpio, 8-15 parts of Radix Astragali, 3-5 parts of the larva of a silkworm with batrytis, 3-5 parts of pheretima and longspur epimedium 3-5 parts raw.
Wherein, 3 parts of Prunella vulgaris, 3 parts of leech, 3 parts of scorpio, 12 parts of Radix Astragali, 4 parts of the larva of a silkworm with batrytis, 4 parts of pheretima and raw longspur epimedium 4 parts.
Invention additionally provides a kind of preparation methods of Chinese herbal granules for treating hypertension, include the following steps:
Step S1: it weighs each ingredient of following mass percent: dropping smell good 10-20 parts, 2-8 parts of rhizoma cyperi, rhizoma anemarrhenae 5-15 Part, 5-15 parts of Cortex Phellodendri, 5-15 parts of HERBA EPIMEDII, 20-40 parts of Huai wheat, 20-40 parts of uncaria and 20-40 parts of mother-of-pearl;
Step S2: it by component materials each in step S1 cleaning, dries, is ground into particle;
Step S3: with laminated aluminum film to get finished product after sterilizing.
Wherein, in the step S1, weighed raw material further include following ingredient by percentage to the quality: mulberry fruit 15- 25 parts, 4-10 parts of Rhizoma Chuanxiong, 6-10 parts of radix achyranthis bidentatae, 5-8 parts of motherwort, 8-12 parts of semen ziziphi spinosae, 9-15 parts of fructus gardeniae, shell of seaear 2-6 Part, 10-20 parts of pueraria lobata and 10-20 parts of rhizoma alismatis.
Wherein, in the step S1, weighed raw material further include following ingredient by percentage to the quality: Prunella vulgaris 2- 4 parts, 2-4 parts of leech, 2-4 parts of scorpio, 8-15 parts of Radix Astragali, 3-5 parts of the larva of a silkworm with batrytis, 3-5 parts of pheretima and longspur epimedium 3-5 parts raw.
The Chinese herbal granules and preparation method thereof for the treatment of hypertension provided by the invention, significant in efficacy, Small side effects and are controlled It is short to treat the period.
Specific embodiment
In order to have further understanding to technical solution of the present invention and beneficial effect, the following detailed description of of the invention Technical solution and its beneficial effect of generation.
The Chinese herbal granules for the treatment of hypertension provided by the invention, are smelt good with drop as main ingredient, first group of drug formulation packet It includes following ingredient by percentage to the quality: dropping smell good 10-20 parts, 2-8 parts of rhizoma cyperi, 5-15 parts of rhizoma anemarrhenae, 5-15 parts of Cortex Phellodendri, celestial being Clever spleen 5-15 parts, 20-40 parts of Huai wheat, 20-40 parts of uncaria and 20-40 parts of mother-of-pearl, preferably, each ingredient in above-mentioned formula Content it is as follows by percentage to the quality: drop smell good 15 parts, 5 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, Huaihe River it is small 30 parts of wheat, 30 parts of uncaria and 30 parts of mother-of-pearl.
The Chinese herbal granules for the treatment of hypertension provided by the invention, second group of drug formulation include by percentage to the quality Following ingredient: 15-25 parts of mulberry fruit, 4-10 parts of Rhizoma Chuanxiong, 6-10 parts of radix achyranthis bidentatae, 5-8 parts of motherwort, 8-12 parts of semen ziziphi spinosae, fructus gardeniae 9-15 parts, 2-6 parts of the shell of seaear, 10-20 parts of pueraria lobata and 10-20 parts of rhizoma alismatis, preferably, in above-mentioned formula each ingredient content with Mass percent meter is as follows: 20 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 8 parts of radix achyranthis bidentatae, 7 parts of motherwort, 10 parts of semen ziziphi spinosae, 12 parts of fructus gardeniae, stone 4 parts of Cassia, 15 parts of pueraria lobata and 15 parts of rhizoma alismatis.
The Chinese herbal granules for the treatment of hypertension provided by the invention, the drug formulation of third group include by percentage to the quality Following ingredient: 2-4 parts of Prunella vulgaris, 2-4 parts of leech, 2-4 parts of scorpio, 8-15 parts of Radix Astragali, 3-5 parts of the larva of a silkworm with batrytis, 3-5 parts of pheretima And raw longspur epimedium 3-5 parts, preferably, the content of each ingredient is as follows by percentage to the quality in above-mentioned formula: 3 parts of Prunella vulgaris, 3 parts of leech, 3 parts of scorpio, 12 parts of Radix Astragali, 4 parts of the larva of a silkworm with batrytis, 4 parts of pheretima and 4 parts of raw longspur epimedium.
In specific medication treatment, first group of drug formulation is essential drug, compared to existing Western medicine or it is other in Medicine, Chinese patent drug have a more obvious therapeutic effect in terms of decompression, the drug formulation of second group and third group reduce it is bad anti- In terms of answering or shortening treatment cycle, play the role of adjuvant treatment to the first group of formula medication, it, can basis in specific treatment The practical constitution status of patient, Symptomatic medicine, by first group of independent medication, alternatively, by first group and second group and third group One of or both mixed reagent.It should be noted that since Chinese medicine is particular about dialectical formula, equilibrium between yin and yang, it is provided by the invention Three groups of drug formulation is all to have done a large amount of theory analysis and clinical trial on the basis of in view of practical medication mechanism It obtains, therefore, in practical medication, is such as intended to select wherein a certain group of formula drug, should select to be covered in the formula Whole drugs, without that should randomly choose.
The drug of three groups of different formulations provided by the invention, the effect played in terms of blood pressure lowering will be by following Embodiment and clinical laboratory data proved.
One, the-the first group of basic recipe drug
Embodiment 1:
Drop is weighed to smell good 15 parts, 5 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part and 30 parts of mother-of-pearl, by each component materials cleaning, dry, be ground into particle.
Embodiment 2:
Drop is weighed to smell good 12 parts, 6 parts of rhizoma cyperi, 7 parts of rhizoma anemarrhenae, 7 parts of Cortex Phellodendri, 7 parts of HERBA EPIMEDII, 25 parts of Huai wheat, 25 parts of uncaria And 25 parts of mother-of-pearl, it by the cleaning of each component materials, dries, is ground into particle.
Embodiment 3:
Drop is weighed to smell good 15 parts, 8 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 35 parts of Huai wheat, uncaria 35 Part and 35 parts of mother-of-pearl, by each component materials cleaning, dry, be ground into particle.
Embodiment 4:
Drop is weighed to smell good 18 parts, 6 parts of rhizoma cyperi, 12 parts of rhizoma anemarrhenae, 12 parts of Cortex Phellodendri, 12 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part and 30 parts of mother-of-pearl, by each component materials cleaning, dry, be ground into particle.
Take Chinese patent drug prepared by above-described embodiment of phase homogenous quantities and commercially available Chinese patent drug (Bezoar pill for lowering blood pressure, calming heart Piece, NAOLIQING etc., respectively with the reference such as comparative example 1, comparative example 2), it is respectively acting on six groups of other patients of difference group, every group of trouble 20 people of person, diastolic pressure is between 100-109mmHg, and systolic pressure is between 160-170mmHg, also, the average of each group patient is relaxed Difference numerical value is no more than 5mmHg between pressure and average systolic, and the basis to guarantee experiment sample was consistent, by 6 weeks control After treatment, mean blood pressure decline situation is as follows:
Table 1: basic recipe therapeutic effect-average systolic fall (mmHg)
Group 1st week 2nd week 4th week 6th week
Embodiment 1 12.33 20.15 25.78 37.33
Embodiment 2 10.13 18.44 22.19 35.44
Embodiment 3 11.57 19.15 21.08 33.72
Embodiment 4 10.94 19.73 22.39 35.47
Comparative example 1 8.31 12.15 15.69 25.03
Comparative example 2 6.45 10.17 14.75 20.48
Table 2: basic recipe therapeutic effect-AvDP fall (mmHg)
Corresponding 80 patients of embodiment 1- embodiment 4 occur adverse reaction 4 (5%), mainly over the course for the treatment of Symptom is out of strength, dizzy.
1 corresponding 20 patient of comparative example occurs adverse reaction 2 (10%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, edema, dizziness, insomnia.
2 corresponding 20 patients of comparative example occur adverse reaction 3 (15%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, has a stuffy nose, is dizzy, out of strength, flushing.
As seen from the above comparison, drug provided by the invention, on antihypertensive effect, hence it is evident that better than existing city's mid-sales at Medicine, also, the occurrence rate of adverse reaction is lower, and symptoms are mild.
Two, the-the first group of mixing formula drug the+the second group drug
Embodiment 5:
Drop is weighed to smell good 15 parts, 5 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part, 30 parts of mother-of-pearl, 20 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 8 parts of radix achyranthis bidentatae, 7 parts of motherwort, 10 parts of semen ziziphi spinosae, 12 parts of fructus gardeniae, the shell of seaear 4 parts, 15 parts of pueraria lobata and 15 parts of rhizoma alismatis by the cleaning of each component materials, dry, are ground into particle.
Embodiment 6:
Weigh drop smell good 12 parts, 6 parts of rhizoma cyperi, 7 parts of rhizoma anemarrhenae, 7 parts of Cortex Phellodendri, 7 parts of HERBA EPIMEDII, 25 parts of Huai wheat, 25 parts of uncaria, 25 parts of mother-of-pearl, 20 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 8 parts of radix achyranthis bidentatae, 7 parts of motherwort, 9 parts of semen ziziphi spinosae, 12 parts of fructus gardeniae, 3 parts of the shell of seaear, 16 parts of pueraria lobata and 10 parts of rhizoma alismatis by the cleaning of each component materials, dry, are ground into particle.
Embodiment 7:
Drop is weighed to smell good 15 parts, 8 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 35 parts of Huai wheat, uncaria 35 Part, 35 parts of mother-of-pearl, 15 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 6 parts of radix achyranthis bidentatae, 8 parts of motherwort, 10 parts of semen ziziphi spinosae, 9 parts of fructus gardeniae, the shell of seaear 2 Part, 20 parts of pueraria lobata and 20 parts of rhizoma alismatis by the cleaning of each component materials, dry, are ground into particle.
Embodiment 8:
Drop is weighed to smell good 18 parts, 6 parts of rhizoma cyperi, 12 parts of rhizoma anemarrhenae, 12 parts of Cortex Phellodendri, 12 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part, 30 parts of mother-of-pearl, 25 parts of mulberry fruit, 4 parts of Rhizoma Chuanxiong, 10 parts of radix achyranthis bidentatae, 8 parts of motherwort, 12 parts of semen ziziphi spinosae, 9 parts of fructus gardeniae, Shi Jue Bright 6 parts, 10 parts of pueraria lobata and 20 parts of rhizoma alismatis by the cleaning of each component materials, dry, are ground into particle.
It is same as described above, takes Chinese patent drug prepared by above-described embodiment of phase homogenous quantities and commercially available Chinese patent drug (ox Yellow chiang ya wan, calming heart piece, NAOLIQING etc., respectively with the reference such as comparative example 1, comparative example 2), it is respectively acting on six groups of difference groups Patient, every group of 20 people of patient, for diastolic pressure between 100-109mmHg, systolic pressure is also, each between 160-170mmHg Difference numerical value is no more than 5mmHg between the AvDP and average systolic of group patient, to guarantee the basis one of experiment sample It causes, after the treatment in 6 week, mean blood pressure decline situation is as follows:
Table 3: mixing formula therapeutic effect-average systolic fall (mmHg)
Table 4: mixing formula therapeutic effect-AvDP fall (mmHg)
Group 1st week 2nd week 4th week 6th week
Embodiment 5 6.01 9.12 14.55 19.53
Embodiment 6 5.64 7.35 10.98 16.17
Embodiment 7 5.15 7.94 11.19 15.77
Embodiment 8 5.97 8.15 12.84 16.95
Comparative example 1 3.21 4.78 6.69 10.03
Comparative example 2 3.45 5.17 6.33 9.96
Corresponding 80 patients of embodiment 5- embodiment 8 occur adverse reaction 1 (1.25%) over the course for the treatment of, Cardinal symptom is slight out of strength, dizzy, and with going deep into for treatment, symptom gradually mitigates and disappears.
1 corresponding 20 patient of comparative example occurs adverse reaction 2 (10%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, edema, dizziness, insomnia.
2 corresponding 20 patients of comparative example occur adverse reaction 3 (15%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, has a stuffy nose, is dizzy, out of strength, flushing.
As seen from the above comparison, second group of drug provided by the invention, in addition to first group of auxiliary of drug is realized more Except good therapeutic effect, additionally it is possible to further decrease the adverse reaction occurred in therapeutic process.
Three, the-the first group of mixing formula drug+third group drug
Embodiment 9:
Drop is weighed to smell good 15 parts, 5 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part, 30 parts of mother-of-pearl, 3 parts of Prunella vulgaris, 3 parts of leech, 3 parts of scorpio, 12 parts of Radix Astragali, 4 parts of the larva of a silkworm with batrytis, 4 parts of pheretima and raw excessive sheep It 4 parts suddenly, by the cleaning of each component materials, dries, is ground into particle.
Embodiment 10:
Weigh drop smell good 12 parts, 6 parts of rhizoma cyperi, 7 parts of rhizoma anemarrhenae, 7 parts of Cortex Phellodendri, 7 parts of HERBA EPIMEDII, 25 parts of Huai wheat, 25 parts of uncaria, 25 parts of mother-of-pearl, 2 parts of Prunella vulgaris, 2 parts of leech, 2 parts of scorpio, 8 parts of Radix Astragali, 5 parts of the larva of a silkworm with batrytis, 5 parts of pheretima and raw longspur epimedium 5 Part, it by the cleaning of each component materials, dries, is ground into particle.
Embodiment 11:
Drop is weighed to smell good 15 parts, 8 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 35 parts of Huai wheat, uncaria 35 Part, 35 parts of mother-of-pearl, 4 parts of Prunella vulgaris, 4 parts of leech, 4 parts of scorpio, 8 parts of Radix Astragali, 3 parts of the larva of a silkworm with batrytis, 3 parts of pheretima and raw excessive sheep It 5 parts suddenly, by the cleaning of each component materials, dries, is ground into particle.
Embodiment 12:
Drop is weighed to smell good 18 parts, 6 parts of rhizoma cyperi, 12 parts of rhizoma anemarrhenae, 12 parts of Cortex Phellodendri, 12 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part, 30 parts of mother-of-pearl, 3 parts of Prunella vulgaris, 3 parts of leech, 3 parts of scorpio, 10 parts of Radix Astragali, 3 parts of the larva of a silkworm with batrytis, 5 parts of pheretima and raw excessive sheep It 5 parts suddenly, by the cleaning of each component materials, dries, is ground into particle.
It is same as described above, takes Chinese patent drug prepared by above-described embodiment of phase homogenous quantities and commercially available Chinese patent drug (ox Yellow chiang ya wan, calming heart piece, NAOLIQING etc., respectively with the reference such as comparative example 1, comparative example 2), it is respectively acting on six groups of difference groups Patient, every group of 20 people of patient, for diastolic pressure between 100-109mmHg, systolic pressure is also, each between 160-170mmHg Difference numerical value is no more than 5mmHg between the AvDP and average systolic of group patient, to guarantee the basis one of experiment sample It causes, after the treatment in 6 week, mean blood pressure decline situation is as follows:
Table 5: mixing formula therapeutic effect-average systolic fall (mmHg)
Group 1st week 2nd week 3rd week 4th week
Embodiment 9 15.71 25.13 30.44 36.18
Embodiment 10 14.91 23.45 28.57 35.55
Embodiment 11 15.07 24.91 29.99 35.81
Embodiment 12 14.88 23.95 28.13 34.97
Comparative example 1 8.31 12.15 13.11 15.69
Comparative example 2 6.45 10.17 12.77 14.75
Table 6: mixing formula therapeutic effect-AvDP fall (mmHg)
Group 1st week 2nd week 3rd week 4th week
Embodiment 9 8.14 11.33 15.17 18.73
Embodiment 10 7.15 10.78 14.18 16.63
Embodiment 11 7.72 10.31 14.89 15.98
Embodiment 12 8.01 9.97 15.01 16.71
Comparative example 1 3.21 4.78 5.18 6.69
Comparative example 2 3.45 5.17 5.03 6.33
Corresponding 80 patients of embodiment 9- embodiment 12 occur adverse reaction 12 (15%), master over the course for the treatment of Wanting symptom is out of strength, dizzy, palpitaition, uncomfortable in chest, flushing.
1 corresponding 20 patient of comparative example occurs adverse reaction 2 (10%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, edema, dizziness, insomnia.
2 corresponding 20 patients of comparative example occur adverse reaction 3 (15%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, has a stuffy nose, is dizzy, out of strength, flushing.
As seen from the above comparison, third group drug can significantly shorten the treatment cycle of basic depressor, imitate decompression Fruit is significantly improved, however, side effect is also more apparent since pharmacological property is stronger, therefore, and in practice, optimal therapeutic modality It is the drug mixing treatment of three kinds of groups.
Four, the+the second group of the-the first group of mixing formula drug drug+third group drug
Embodiment 13:
Drop is weighed to smell good 15 parts, 5 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part, 30 parts of mother-of-pearl, 20 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 8 parts of radix achyranthis bidentatae, 7 parts of motherwort, 10 parts of semen ziziphi spinosae, 12 parts of fructus gardeniae, the shell of seaear 4 parts, 15 parts of pueraria lobata, 15 parts of rhizoma alismatis, 3 parts of Prunella vulgaris, 3 parts of leech, 3 parts of scorpio, 12 parts of Radix Astragali, 4 parts of the larva of a silkworm with batrytis, 4 parts of pheretima And raw 4 parts of longspur epimedium, it by the cleaning of each component materials, dries, is ground into particle.
Embodiment 14:
Weigh drop smell good 12 parts, 6 parts of rhizoma cyperi, 7 parts of rhizoma anemarrhenae, 7 parts of Cortex Phellodendri, 7 parts of HERBA EPIMEDII, 25 parts of Huai wheat, 25 parts of uncaria, 25 parts of mother-of-pearl, 20 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 8 parts of radix achyranthis bidentatae, 7 parts of motherwort, 9 parts of semen ziziphi spinosae, 12 parts of fructus gardeniae, 3 parts of the shell of seaear, 16 parts of pueraria lobata, 10 parts of rhizoma alismatis, 2 parts of Prunella vulgaris, 2 parts of leech, 2 parts of scorpio, 8 parts of Radix Astragali, 5 parts of the larva of a silkworm with batrytis, 5 parts of pheretima and life It 5 parts of longspur epimedium, by the cleaning of each component materials, dries, is ground into particle.
Embodiment 15:
Drop is weighed to smell good 15 parts, 8 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 35 parts of Huai wheat, uncaria 35 Part, 35 parts of mother-of-pearl, 15 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 6 parts of radix achyranthis bidentatae, 8 parts of motherwort, 10 parts of semen ziziphi spinosae, 9 parts of fructus gardeniae, the shell of seaear 2 Part, 20 parts of pueraria lobata, 20 parts of rhizoma alismatis, 4 parts of Prunella vulgaris, 4 parts of leech, 4 parts of scorpio, 8 parts of Radix Astragali, 3 parts of the larva of a silkworm with batrytis, 3 parts of pheretima and 5 parts of raw longspur epimedium by the cleaning of each component materials, dries, is ground into particle.
Embodiment 16:
Drop is weighed to smell good 18 parts, 6 parts of rhizoma cyperi, 12 parts of rhizoma anemarrhenae, 12 parts of Cortex Phellodendri, 12 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part, 30 parts of mother-of-pearl, 25 parts of mulberry fruit, 4 parts of Rhizoma Chuanxiong, 10 parts of radix achyranthis bidentatae, 8 parts of motherwort, 12 parts of semen ziziphi spinosae, 9 parts of fructus gardeniae, Shi Jue Bright 6 parts, 10 parts of pueraria lobata, 20 parts of rhizoma alismatis, 3 parts of Prunella vulgaris, 3 parts of leech, 3 parts of scorpio, 10 parts of Radix Astragali, 3 parts of the larva of a silkworm with batrytis, 5 parts of pheretima And raw 5 parts of longspur epimedium, it by the cleaning of each component materials, dries, is ground into particle.
It is same as described above, takes Chinese patent drug prepared by above-described embodiment of phase homogenous quantities and commercially available Chinese patent drug (ox Yellow chiang ya wan, calming heart piece, NAOLIQING etc., respectively with the reference such as comparative example 1, comparative example 2), it is respectively acting on six groups of difference groups Patient, every group of 20 people of patient, for diastolic pressure between 100-109mmHg, systolic pressure is also, each between 160-170mmHg Difference numerical value is no more than 5mmHg between the AvDP and average systolic of group patient, to guarantee the basis one of experiment sample It causes, after the treatment in 6 weeks, mean blood pressure decline situation is as follows:
Table 7: mixing formula therapeutic effect-average systolic fall (mmHg)
Table 8: mixing formula therapeutic effect-AvDP fall (mmHg)
Group 1st week 2nd week 3rd week 4th week
Embodiment 13 7.16 10.13 14.73 16.77
Embodiment 14 6.85 9.99 13.11 16.13
Embodiment 15 6.72 8.91 14.09 15.08
Embodiment 16 6.01 9.17 13.17 15.71
Comparative example 1 3.21 4.78 5.18 6.69
Comparative example 2 3.45 5.17 5.03 6.33
Corresponding 80 patients of embodiment 13- embodiment 16 occur adverse reaction 6 (7.5%) over the course for the treatment of, Wherein 5 cardinal symptoms are out of strength, dizzy, flushing, and in addition 1 cardinal symptom is palpitaition, uncomfortable in chest, flushing.
1 corresponding 20 patient of comparative example occurs adverse reaction 2 (10%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, edema, dizziness, insomnia.
2 corresponding 20 patients of comparative example occur adverse reaction 3 (15%) over the course for the treatment of, and cardinal symptom is the heart Throb with fear, is uncomfortable in chest, has a stuffy nose, is dizzy, out of strength, flushing.
As seen from the above comparison, it after three groups of pharmaceutical composition, during treating hypertension, is controlled compared to more existing The Chinese medicine or Chinese patent drug of hypertension are treated, antihypertensive effect is obvious, and treatment cycle is short, and adverse reaction is also small, in addition, passing through above-mentioned several groups Comparative experiments will also realize that the therapeutic agent of third group, drug effect is more violent, also, the drug cost of third group is also higher, therefore, In clinical treatment, generally directed to the patient for needing to treat as early as possible that is in a bad way.
The present invention over the course for the treatment of, furthermore with embodiment 1 provide drug, the patient more serious to a symptom into Go detailed tracking follow-up, follow-up situation is as follows:
Mrs Liu, discovery blood pressure increases when physical examination before 57 years old, patient 10 years, is never interrupted over 10 years and takes depressor, blood Pressure is not controlled effectively, and fluctuation of blood pressure is in 170-210/95-120mmHg.Dizziness headache is felt when patient, the whole body is out of strength, loses Dormancy amnesia, receives few, and drinking-water is few, and sleep still, is defecated partially dry, and urine is fine, has a blood test and presses 220/110mmHg, and heart rate 76 times/ Point.Patient is also at 10 milligrams, ethyldopa 0.25mg of oral nifepine, 3 times a day.
X piece shows: left ventricular hypertrophy.Electrocardio diagram: left axis deviation, left ventricular hypertrophy.Look into creatinine, urea nitrogen is in just Ordinary water is flat.The dark red tongue fur of patient's tongue is yellowish, veins string.Doctor trained in Western medicine diagnosis are as follows: II phase of hypertension.Chinese medical discrimination are as follows: deficiency of qi and blood.
This granule is taken orally, is taken after mixing it with water with appropriate hot water, respectively takes 1 time sooner or later, one after each meal.After taking 5 doses, patient's dizziness, Symptom nauseous, out of strength has been clearly better, and measuring blood pressure is reduced to 145/85mmHg.Even served a course for the treatment of, clinical symptoms disappear substantially, Measuring blood pressure fluctuates between 130-150/95-90mmHg.Patient's recovery from illness.Follow-up 2 months, stable disease.
Beneficial effects of the present invention are as follows:
1, by drop smell good, rhizoma cyperi, rhizoma anemarrhenae, Cortex Phellodendri, HERBA EPIMEDII, Huai wheat, uncaria and mother-of-pearl addition and its match The adjustment of side, improves antihypertensive effect.
2, by the addition of mulberry fruit, Rhizoma Chuanxiong, radix achyranthis bidentatae, motherwort, semen ziziphi spinosae, fructus gardeniae, the shell of seaear, pueraria lobata and rhizoma alismatis and Its adjustment being formulated improves the adverse reaction during medication.
3, pass through the addition of Prunella vulgaris, leech, scorpio, Radix Astragali, the larva of a silkworm with batrytis, pheretima and raw longspur epimedium and its tune of formula It is whole, shorten treatment cycle.
Although the present invention is illustrated using above-mentioned preferred embodiment, the protection model that however, it is not to limit the invention It encloses, anyone skilled in the art are not departing within the spirit and scope of the present invention, and opposite above-described embodiment carries out various changes It is dynamic still to belong to the range that the present invention is protected with modification, therefore protection scope of the present invention subjects to the definition of the claims.

Claims (9)

1. a kind of Chinese herbal granules for treating hypertension, it is characterised in that: including following ingredient by percentage to the quality: drop is true 10-20 parts fragrant, 2-8 parts of rhizoma cyperi, 5-15 parts of rhizoma anemarrhenae, 5-15 parts of Cortex Phellodendri, 5-15 parts of HERBA EPIMEDII, 20-40 parts of Huai wheat, uncaria 20- 40 parts and 20-40 parts of mother-of-pearl.
2. the Chinese herbal granules for the treatment of hypertension as described in claim 1, it is characterised in that: the content of each ingredient is with quality hundred Divide as follows than counting: dropping smell good 15 parts, 5 parts of rhizoma cyperi, 10 parts of rhizoma anemarrhenae, 10 parts of Cortex Phellodendri, 10 parts of HERBA EPIMEDII, 30 parts of Huai wheat, uncaria 30 Part and 30 parts of mother-of-pearl.
3. the Chinese herbal granules for the treatment of hypertension as described in claim 1, it is characterised in that: further include by percentage to the quality Following ingredient: 15-25 parts of mulberry fruit, 4-10 parts of Rhizoma Chuanxiong, 6-10 parts of radix achyranthis bidentatae, 5-8 parts of motherwort, 8-12 parts of semen ziziphi spinosae, fructus gardeniae 9-15 parts, 2-6 parts of the shell of seaear, 10-20 parts of pueraria lobata and 10-20 parts of rhizoma alismatis.
4. the Chinese herbal granules for the treatment of hypertension as claimed in claim 3, it is characterised in that: further include by percentage to the quality Following ingredient: 20 parts of mulberry fruit, 6 parts of Rhizoma Chuanxiong, 8 parts of radix achyranthis bidentatae, 7 parts of motherwort, 10 parts of semen ziziphi spinosae, 12 parts of fructus gardeniae, the shell of seaear 4 Part, 15 parts of pueraria lobata and 15 parts of rhizoma alismatis.
5. the Chinese herbal granules for the treatment of hypertension as described in claim 1, it is characterised in that: further include by percentage to the quality Following ingredient: 2-4 parts of Prunella vulgaris, 2-4 parts of leech, 2-4 parts of scorpio, 8-15 parts of Radix Astragali, 3-5 parts of the larva of a silkworm with batrytis, 3-5 parts of pheretima with And raw longspur epimedium 3-5 parts.
6. the Chinese herbal granules for the treatment of hypertension as claimed in claim 5, it is characterised in that: further include by percentage to the quality Following ingredient: 3 parts of Prunella vulgaris, 3 parts of leech, 3 parts of scorpio, 12 parts of Radix Astragali, 4 parts of the larva of a silkworm with batrytis, 4 parts of pheretima and raw longspur epimedium 4 Part.
7. a kind of preparation method for the Chinese herbal granules for treating hypertension, which comprises the steps of:
Step S1: it weighs each ingredient of following mass percent: dropping smell good 10-20 parts, 2-8 parts of rhizoma cyperi, 5-15 parts of rhizoma anemarrhenae, Cortex Phellodendri 5-15 parts, 5-15 parts of HERBA EPIMEDII, 20-40 parts of Huai wheat, 20-40 parts of uncaria and 20-40 parts of mother-of-pearl;
Step S2: it by component materials each in step S1 cleaning, dries, is ground into particle;
Step S3: with laminated aluminum film to get finished product after sterilizing.
8. the preparation method of the Chinese herbal granules for the treatment of hypertension as claimed in claim 7, it is characterised in that: the step S1 In, weighed raw material further include following ingredient by percentage to the quality: 15-25 parts of mulberry fruit, 4-10 parts of Rhizoma Chuanxiong, radix achyranthis bidentatae 6-10 Part, 5-8 parts of motherwort, 8-12 parts of semen ziziphi spinosae, 9-15 parts of fructus gardeniae, 2-6 parts of the shell of seaear, 10-20 parts of pueraria lobata and rhizoma alismatis 10-20 Part.
9. the preparation method of the Chinese herbal granules for the treatment of hypertension as claimed in claim 7 or 8, it is characterised in that: the step In rapid S1, weighed raw material further include following ingredient by percentage to the quality: 2-4 parts of Prunella vulgaris, 2-4 parts of leech, scorpio 2-4 parts, 8-15 parts of Radix Astragali, 3-5 parts of the larva of a silkworm with batrytis, 3-5 parts of pheretima and longspur epimedium 3-5 parts raw.
CN201910231256.6A 2019-03-26 2019-03-26 A kind of Chinese herbal granules and preparation method thereof for treating hypertension Pending CN110038089A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910231256.6A CN110038089A (en) 2019-03-26 2019-03-26 A kind of Chinese herbal granules and preparation method thereof for treating hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910231256.6A CN110038089A (en) 2019-03-26 2019-03-26 A kind of Chinese herbal granules and preparation method thereof for treating hypertension

Publications (1)

Publication Number Publication Date
CN110038089A true CN110038089A (en) 2019-07-23

Family

ID=67275154

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910231256.6A Pending CN110038089A (en) 2019-03-26 2019-03-26 A kind of Chinese herbal granules and preparation method thereof for treating hypertension

Country Status (1)

Country Link
CN (1) CN110038089A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115531451A (en) * 2022-10-13 2022-12-30 李含朋 Traditional Chinese medicine composition for preventing and conditioning hypertension and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1994367A (en) * 2006-12-21 2007-07-11 中国科学院南海海洋研究所 Marine medicine for treating hypertension, preparation process and dispersible tablet thereof
CN101269158A (en) * 2007-03-21 2008-09-24 北京亚东生物制药有限公司 Medicament combination for treating hypertension, preparation method and quality control method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1994367A (en) * 2006-12-21 2007-07-11 中国科学院南海海洋研究所 Marine medicine for treating hypertension, preparation process and dispersible tablet thereof
CN101269158A (en) * 2007-03-21 2008-09-24 北京亚东生物制药有限公司 Medicament combination for treating hypertension, preparation method and quality control method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
吴寿岭等: "《临床高血压病学》", 31 January 2015, 北京大学医学出版社 *
张苏慧等: ""超临界CO2萃取斜叶黄檀精油工艺优化及精油成分分析"", 《热带作物学报》 *
李亚平: "《高血压中医保健》", 31 January 2000, 人民卫生出版社 *
莫望春: ""中药配方颗粒与中药饮片治疗原发性高血压临床对比研究"", 《北方药学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115531451A (en) * 2022-10-13 2022-12-30 李含朋 Traditional Chinese medicine composition for preventing and conditioning hypertension and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1325083C (en) Medicinal composition for removing dampness to relieve itching and its preparation method and uses
CN102698121B (en) Traditional Chinese medicinal composition for treating paradentitis and preparation method thereof and toothpaste
CN102139030A (en) Oral Chinese herbal preparation for treating gingivitis and preparation method thereof
CN104906066A (en) Lincomycin hydrochloride compound vaginal effervescent tablets and preparation method thereof
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN103860978B (en) A kind of Chinese medicine preparation for the treatment of decubital ulcer and preparation method thereof
CN101579186B (en) Pharmaceutical rhinitis pillow for external use and treating wind-heat rhinitis
CN1327875C (en) Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method
CN103977281A (en) Traditional Chinese medicine composition for treating female endocrine disorders and preparation method thereof
CN110038089A (en) A kind of Chinese herbal granules and preparation method thereof for treating hypertension
CN103341092A (en) Preparation method of powder for treating atrophic vaginitis
CN104706953A (en) Traditional Chinese medicine preparation for treating chronic cervicitis
CN102579818A (en) Traditional Tibetan medicine composition, preparation method thereof and application
CN104998158A (en) Pharmaceutical composition for treating liver cirrhosis and application thereof
CN110478416A (en) The composition and its preparation method and application for treating rheumatic rheumatoid arthritis
CN115837065B (en) Traditional Chinese medicine composition and application thereof
CN104096103A (en) Traditional Chinese medicine agent for treating uroschesis
CN103479915B (en) Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof
CN112138105B (en) Traditional Chinese medicine composition for treating bronchiectasis lung-spleen qi deficiency and phlegm-damp lung blocking syndrome and application thereof
CN105288212A (en) Traditional Chinese medicine composition for treating yin deficiency fire excess type insomnia and preparing method thereof
CN105194457A (en) Chinese herba preparation for lymphangitis and preparation method thereof
CN105343688A (en) Medicine composition for treating myocardial infarction and application thereof
CN105213975A (en) A kind of pharmaceutical composition and application thereof for the treatment of liver cirrhosis
CN104491557A (en) Drug for treating blocking gastrointestinal type type organophosphorus pesticide pesticide intoxication and preparation method for drug
CN104688855A (en) Coptidis rhizome and donkey-hide glue composition for the treatment of chronic fatigue syndrome and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190723

RJ01 Rejection of invention patent application after publication